Tiziana Apuzzo

ORCID: 0000-0002-2852-5461
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • CAR-T cell therapy research
  • Immunotherapy and Immune Responses
  • RNA modifications and cancer
  • Protein Tyrosine Phosphatases
  • Chemokine receptors and signaling
  • Cancer Cells and Metastasis
  • Immune Cell Function and Interaction
  • Cancer, Hypoxia, and Metabolism
  • Ferroptosis and cancer prognosis
  • interferon and immune responses
  • Immune cells in cancer
  • Cancer-related Molecular Pathways
  • Protein Degradation and Inhibitors
  • Cancer Research and Treatments
  • Mathematical Biology Tumor Growth
  • T-cell and B-cell Immunology
  • Cytokine Signaling Pathways and Interactions
  • Cancer Genomics and Diagnostics
  • Pancreatic and Hepatic Oncology Research
  • Mesenchymal stem cell research
  • Galectins and Cancer Biology
  • Cell death mechanisms and regulation
  • Systemic Sclerosis and Related Diseases
  • Monoclonal and Polyclonal Antibodies Research
  • Neuroblastoma Research and Treatments

University of Palermo
2014-2021

After tissue damage, inflammatory cells infiltrate the and release proinflammatory cytokines. HMGB1 (high mobility group box 1), a nuclear protein released by necrotic severely stressed cells, promotes cytokine via its interaction with TLR4 (Toll-like receptor 4) cell migration an unknown mechanism. We show that HMGB1-induced recruitment of depends on CXCL12. CXCL12 form heterocomplex, which we characterized magnetic resonance surface plasmon resonance, acts exclusively through CXCR4 not...

10.1084/jem.20111739 article EN cc-by-nc-sa The Journal of Experimental Medicine 2012-02-27

Background Leukocyte migration is essential for effective host defense against invading pathogens and during immune homeostasis. A hallmark of the regulation this process presentation chemokines in gradients stimulating leukocyte chemotaxis via cognate chemokine receptors. For efficient migration, receptor responsiveness must be maintained whilst cells crawl on cell surfaces or matrices along attracting gradient towards increasing concentrations agonist. On other hand agonist-induced...

10.1371/journal.pone.0037208 article EN cc-by PLoS ONE 2012-05-17

Current combined surgical and neo-adjuvant chemotherapy of primary metastatic osteosarcoma (OS) is ineffective, reflected by a 5-year survival rate affected patients less than 20 %. Studies in experimental OS metastasis models pointed to the CXCR4/CXCL12 homing axis as novel target for metastasis-suppressive treatment. The present study investigated first time CXCR4-blocking principle spontaneously metastasizing human 143B cell line-derived orthotopic xenograft mouse model. highly cells,...

10.1007/s10585-013-9632-3 article EN cc-by Clinical & Experimental Metastasis 2014-01-03

It has been proposed that mesenchymal stromal cells (MSCs) promote tumor progression by interacting with and other stroma in the complex network of microenvironment. We characterized MSCs isolated expanded from tissues pediatric patients diagnosed neuroblastomas (NB-MSCs) to define interactions microenvironment.Specimens were obtained 7 neuroblastoma (NB). Morphology, immunophenotype, differentiation capacity, proliferative growth, expression stemness neural markers evaluated. Moreover,...

10.1186/s12885-018-5082-2 article EN cc-by BMC Cancer 2018-11-27

Abstract The tumor microenvironment supplies proinflammatory cytokines favoring a permissive milieu for cancer cell growth and invasive behavior. Here we show how breast progression is facilitated by IL4 secreted adipose tissue estrogen receptor–positive triple-negative types. Blocking autocrine paracrine signaling with the IL4Rα antagonist IL4DM compromised proliferation, invasion, downregulating MAPK pathway activity. reduced numbers of CD44+/CD24− stem-like cells elevated expression dual...

10.1158/0008-5472.can-16-3126 article EN Cancer Research 2017-04-12

The use of stem cells, including mesenchymal cells (MSCs), for regenerative medicine is gaining interest the clinical benefits so far obtained in patients. This study investigates adipose autologous tissue combination with platelet-rich plasma (PRP) to improve outcome patients affected by systemic sclerosis (SSc). Adipose-derived (AD-MSCs) and PRPs were purified from healthy donors SSc multilineage differentiation potential AD-MSCs their genotypic–phenotypic features investigated. A cytokine...

10.1186/s13287-017-0690-3 article EN cc-by Stem Cell Research & Therapy 2017-10-23

Immune checkpoint blockade therapy has changed prognoses for many melanoma patients. However, immune responses that correlate with clinical progression of the disease are still poorly understood. To identify correlating evolution, we analyzed serum cytokines as well circulating NK and T-cell subpopulations from The patients' profiles suggested leads to changes in peripheral blood subsets. Stage IV was characterized by an increased frequency CCR7+CD56bright cells high concentrations CCR7...

10.1158/2326-6066.cir-18-0651 article EN Cancer Immunology Research 2019-04-02

Abstract Despite intense research and clinical efforts, patients affected by advanced colorectal cancer (CRC) have still a poor prognosis. The discovery of (CR) stem cell (CSC) as the compartment responsible for tumor initiation propagation may provide new opportunities development therapeutic strategies. Given reduced sensitivity CR-CSCs to chemotherapy ability bone morphogenetic proteins (BMP) promote colonic differentiation, we aimed investigate whether an enhanced variant BMP7 (BMP7v)...

10.1038/s41388-019-1047-4 article EN cc-by Oncogene 2019-10-07

P63 is a transcription factor belonging to the family of p53, essential for development and differentiation epithelia. In recent years, it has become clear that altered expression different isoforms this gene can play an important role in carcinogenesis. The p63 encodes two main known as TA ΔN with functions. these sustaining tumor progression metastatic spreading however not entirely been clarified. Here we show breast cancer initiating cells express ΔNp63 isoform supports more mesenchymal...

10.18632/oncotarget.11022 article EN Oncotarget 2016-08-02

Background Cancer stem cells represent a population of immature tumor found in most solid tumors. Their peculiar features make them ideal models for studying drug resistance and sensitivity. In this study, we investigated whether cancer isolation vitro sensitivity assay are feasible clinical setting. Methods were isolated from effusions or fresh tissue 23 patients who progressed after standard therapy failure. Specific culture conditions selected that express markers stemness. These exposed...

10.1371/journal.pone.0125037 article EN cc-by PLoS ONE 2015-05-08

Chemokine receptors are key regulators of leukocyte trafficking but also have an important role in development, tumor growth, and metastasis. Among the chemokine receptors, CXCR4 is only one that leads to perinatal death when genetically ablated mice, indicating a more-widespread function development. To identify pathways activated downstream CXCR4, solubilization protocol was elaborated, which allows for isolation endogenous receptor from human cells its near-native conformation....

10.1189/jlb.2ma0915-415r article EN Journal of Leukocyte Biology 2015-11-25

Abstract Background: Despite the advent of successful treatment localized malignancies, metastatic cancer still lacks efficacious therapeutic approaches, including breast cancer. It is now well established that within malignant tumors Cancer Stem Cells (CSCs) constitute a unique cell subset fuel and succeed at tumor growth metastases formation. Tumor microenvironment sustains CSCs characteristics, making molecular mechanisms driving progression recurrence more complex difficult to elucidate....

10.1158/1538-7445.am2016-3311 article EN Cancer Research 2016-07-15

<div>Abstract<p>The tumor microenvironment supplies proinflammatory cytokines favoring a permissive milieu for cancer cell growth and invasive behavior. Here we show how breast progression is facilitated by IL4 secreted adipose tissue estrogen receptor–positive triple-negative types. Blocking autocrine paracrine signaling with the IL4Rα antagonist IL4DM compromised proliferation, invasion, downregulating MAPK pathway activity. reduced numbers of...

10.1158/0008-5472.c.6508551.v1 preprint EN 2023-03-31
Coming Soon ...